[3H]GBR 12935 binding to dopamine uptake sites: subcellular localizatio and reduction in Parkinson's disease and progressive supranuclear palsy
- 1 November 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 156 (3), 331-340
- https://doi.org/10.1016/0014-2999(88)90278-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- [3H]GBR 12935 binding in vivo in mouse brain: labelling of a piperazine acceptor siteEuropean Journal of Pharmacology, 1987
- Biochemical and Pharmacological Characterization of [3H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake ComplexJournal of Neurochemistry, 1987
- The regional distribution of dopamine and serotonin uptake and transmitter concentrations in the human brainNeurochemistry International, 1987
- High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous systemEuropean Journal of Pharmacology, 1986
- GBR 12783, a potent and selective inhibitor of dopamine uptake: Biochemical studies in vivo and ex vivoEuropean Journal of Pharmacology, 1986
- Characterization of [3H]paroxetine binding to rat cortical membranesEuropean Journal of Pharmacology, 1985
- Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranesBiochemical Pharmacology, 1985
- [3H]GBR-12935: A specific high affinity ligand for labeling the dopamine transport complexEuropean Journal of Pharmacology, 1985
- [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsyEuropean Journal of Pharmacology, 1984
- Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1971